explore -WSS

explore

author：focus 2025-10-04 07:15:31 - browse：28

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Shionogi licenses Pompe disease therapy from Maze Therapeutics

WSS

For BCIs, commercial hurdles may be bigger than scientific ones

Brain worms: The science behind RFK Jr.'s parasitic infection

CDC wastewater surveillance dashboard to track bird flu hotspots

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Attacks on the drug industry will lead to fewer breakthroughs

Apple Watch's A

focus

explore

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Verily hires former Apple Health leader as chief scientific officer

Heart attack and stroke risk calculators need revising

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Alkermes shareholders re

ProMED, early warning system on disease outbreaks, in peril

ChatGPT in medicine: STAT answers readers' burning questions

Steward Health Care files for bankruptcy

hotspot

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Telehealth startups turn to complex chronic diseases

Biden calls for immediate release of Niger's president amid apparent coup

Medicare says breakthrough device reimbursement rule to come by summer

Use wet bulb globe temperature, not heat index, to protect workers

Dramatically reducing cancer deaths requires the PASTEUR Act

hotspot

entertainment

explore

entertainment